The significant systemic reduction in key inflammatory markers (IL-6 and TNFα) highlights clearly the impact of successfully treating a local infection and corresponds well with findings in humans, where periodontitis-affected patients have higher levels of inflammation markers compared with periodontal healthy people [49,50,51,52]. The gene discussed is IL6; the disease is infection.